Full-Time

Sr. Lab Informatics Specialist

Posted on 1/26/2024

Natera

Natera

1,001-5,000 employees

Biotechnology firm specializing in genetic testing

Compensation Overview

$121.1k - $151.4k/yr

Senior

Company Historically Provides H1B Sponsorship

Remote in USA

The job posting mentions a pay range for remote work in the USA, indicating that the position is open to candidates located anywhere in the United States. The company, Natera, is committed to ensuring a diverse and inclusive workplace environment, welcoming people of different backgrounds, experiences, abilities, and perspectives.

Category
Software Engineering
Required Skills
JavaScript
Groovy
SQL
Java
AWS
JIRA
Linux/Unix
Requirements
  • Minimum of 8 years of relevant experience, including 5+ years of direct experience in software application development
  • Experience working with users to configure data management software to meet business workflow requirements
  • Experience in creating commercial software product requirements and managing a product backlog
  • Experience working with relational databases and creating SQL queries, especially Oracle
  • Knowledge in LIMS, LIS, LES, and/or ELN, especially LabVantage
  • Comfortable with Linux command line usage
  • Some programming or scripting knowledge (Java, Groovy, JavaScript)
  • Cloud/AWS basics
Responsibilities
  • Configure LabVantage to implement features and changes for maintenance releases and new product development
  • Translate laboratory needs into technical product requirements and specifications
  • Act as a subject matter expert on LabVantage to provide guidance to stakeholders and create a shared understanding among business and technical teams
  • Produce deliverables such as flow diagrams, data models, prototypes, wireframes, and other illustrations
  • Maintain tracking of requests from user groups and prioritize those for time allotment and release planning
  • Assist in software quality assurance with testing of changes in LabVantage
  • Assist engineering production support with resolving LabVantage issues and investigations
  • Assist in assembly of reports needed for regulatory compliance requirements
  • Suggest and drive introduction of departmental practice changes and tools that will improve quality and organization of LabVantage engineering work
  • Oversee work and delegate tasks to other engineering team members when needed
  • Act as a mentor and help to develop more junior Laboratory Informatics Specialist team members
  • Complete training relating to HIPAA/PHI privacy, General Policies and Procedure Compliance training, and security training within the first 30 days of hire
Desired Qualifications
  • Experience with JIRA or similar issue tracking system
  • Knowledge of laboratory processes and instrumentation
  • Comfortable contributing to and leading meetings with business partners in a variety of positions and domain areas to receive product requests and guide decision-making
  • Ability to understand and describe technical complexities in a simplified way appropriate to different audiences
  • Excellent written communication skills to produce clear, concise and correct technical documentation
  • Strong ability to comprehend complex problems and apply knowledge to propose potential solutions
  • Analytical skills to understand the needs of customers and work out priorities

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and monitor organ health. Natera also offers tests for family planning and prenatal screening, including the Panorama NIPT, which has conducted over 2 million tests. The company generates revenue through testing services and kits, often reimbursed by insurance, and provides genetic counseling for personalized patient support.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Austin, Texas

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • AI integration enhances accuracy and speed of Natera's cfDNA analysis.
  • Growing personalized medicine trend aligns with Natera's custom-built ctDNA tests.

What critics are saying

  • Increased competition from companies like Lantheus Holdings threatens market share.
  • Recent CFO stock sale may indicate concerns about Natera's financial health.
  • Multiple trial launches could strain resources and lead to operational challenges.

What makes Natera unique

  • Natera specializes in cell-free DNA testing for diverse medical needs.
  • Their Signatera test offers custom-built ctDNA solutions for cancer patients.
  • Natera's Panorama NIPT has achieved over 2 million tests conducted.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

5%
TXBN
Apr 24th, 2025
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera(TM) Genome MRD Test

Natera announces broad clinical launch of ultra-sensitive signatera(tm) genome MRD test.

Slater Sentinel
Apr 3rd, 2025
DnB Asset Management AS Invests $235,000 in Natera, Inc. (NASDAQ:NTRA)

DnB Asset Management AS invests $235,000 in Natera, Inc. (NASDAQ:NTRA).

TXBN
Mar 25th, 2025
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

AUSTIN, Texas - (BUSINESS WIRE) - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting on April 29, 2025.

Simply Wall St
Mar 13th, 2025
Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board

Last week, Natera (NasdaqGS:NTRA) announced a strategic expansion of its Board of Directors with the appointment of Monica Bertagnolli.

Investing.com
Mar 10th, 2025
Natera launches HEROES trial for breast cancer treatment

Natera launches HEROES trial for breast cancer treatment.

INACTIVE